Nevertheless, one study analyzed the characteristics of the BM-MSCs from MS patients in vitro, and it concluded that BM-MSCs from individuals with MS, compared to individuals without MS, displayed a normal phenotype and were similar in proliferation, in vitro differentiation potential and cell surface antigen expression [44]. This evidence concerns the gene CD53 and myeloid sarcoma.